The dual effects of nanomaterials on sperm and seminal fluid oxidative stress
- PMID: 40822929
- PMCID: PMC12355594
- DOI: 10.1016/j.mtbio.2025.102163
The dual effects of nanomaterials on sperm and seminal fluid oxidative stress
Abstract
Nanomaterials, due to their unique physicochemical properties, have found widespread applications in biomedical, energy, and environmental fields. Currently, their effects on the male reproductive system are also under investigation. Oxidative stress, a pathological condition resulting from an imbalance between the generation and clearance of reactive oxygen species (ROS), is a critical mechanism affecting male reproductive function. Therefore, this review focuses on the regulatory mechanisms of various nanomaterials on semen oxidative stress, synthesizing literature data and evaluating their effects and molecular underpinnings. Previous studies indicate that nanomaterials exhibit dual effects: some materials (e.g. selenium, cerium dioxide nanoparticles) mimic the activity of superoxide dismutase (SOD) and catalase (CAT), or enhance endogenous antioxidant systems such as glutathione peroxidase (GPx), significantly reducing ROS levels and improving sperm motility, membrane integrity, and DNA stability. Conversely, other materials (e.g., silver nanoparticles, silica nanoparticles) release surface metal ions, activate inflammatory pathways, or impair mitochondrial function, triggering Fenton reactions and excessive ROS accumulation, leading to lipid peroxidation, DNA fragmentation, and reproductive cell apoptosis. Furthermore, the effects of nanomaterials are influenced by their physicochemical characteristics (e.g., size, modification), exposure dose, administration route, and research models. Surface functionalization (e.g., antioxidant loading, polymer coating) can effectively modulate their outcomes. This review emphasizes the need for a careful balance between the antioxidant potential and pro-oxidant risks of nanomaterials in reproductive medicine. Future studies should focus on multi-scale toxicity assessments, standardized model development, and optimized targeted delivery strategies to promote the sustainable application of nanomaterials in male infertility treatment and sperm preservation technologies.
Keywords: DNA fragmentation; Nanomaterial; Oxidative stress; Reactive oxygen species; Semen.
© 2025 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures






Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Heavy metals: toxicity and human health effects.Arch Toxicol. 2025 Jan;99(1):153-209. doi: 10.1007/s00204-024-03903-2. Epub 2024 Nov 20. Arch Toxicol. 2025. PMID: 39567405 Free PMC article. Review.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
Incubation of semen with human follicular fluid improves the antioxidant status and quality of spermatozoa after freezing-thawing.Reprod Fertil. 2025 Jun 26;6(2):e240056. doi: 10.1530/RAF-24-0056. Print 2025 Apr 1. Reprod Fertil. 2025. PMID: 40460191 Free PMC article.
-
Antioxidants for male subfertility.Cochrane Database Syst Rev. 2014;(12):CD007411. doi: 10.1002/14651858.CD007411.pub3. Epub 2014 Dec 15. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2019 Mar 14;3:CD007411. doi: 10.1002/14651858.CD007411.pub4. PMID: 25504418 Updated.
References
-
- Hrkach J., Von Hoff D., Mukkaram Ali M., Andrianova E., Auer J., Campbell T., De Witt D., Figa M., Figueiredo M., Horhota A., Low S., McDonnell K., Peeke E., Retnarajan B., Sabnis A., Schnipper E., Song J.J., Song Y.H., Summa J., Tompsett D., Troiano G., Van Geen Hoven T., Wright J., LoRusso P., Kantoff P.W., Bander N.H., Sweeney C., Farokhzad O.C., Langer R., Zale S. Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci. Transl. Med. 2012;4(128):128ra39. doi: 10.1126/scitranslmed.3003651. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous